Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation.

Kanayama M, Daniels VA, Gielzak M, Brame A, Han M, Jia L, Xu J, Lotan TL, Eisenberger MA, Marshall CH, Walsh PC, Isaacs WB, Luo J.

Open source

DOI: 10.1002/pros.70133
Published: 2026-01-22
Container: Prostate
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/pros.70133,
  title = {Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation.},
  author = {Kanayama M and  Daniels VA and  Gielzak M and  Brame A and  Han M and  Jia L and  Xu J and  Lotan TL and  Eisenberger MA and  Marshall CH and  Walsh PC and  Isaacs WB and  Luo J.},
  year = {2026},
  journal = {Prostate},
  doi = {10.1002/pros.70133},
  url = {https://doi.org/10.1002/pros.70133}
}

RIS

TY  - JOUR
TI  - Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation.
AU  - Kanayama M
AU  -  Daniels VA
AU  -  Gielzak M
AU  -  Brame A
AU  -  Han M
AU  -  Jia L
AU  -  Xu J
AU  -  Lotan TL
AU  -  Eisenberger MA
AU  -  Marshall CH
AU  -  Walsh PC
AU  -  Isaacs WB
AU  -  Luo J.
PY  - 2026
JO  - Prostate
DO  - 10.1002/pros.70133
UR  - https://doi.org/10.1002/pros.70133
ER  -

APA

M, K., VA, D., M, G., A, B., M, H., L, J., J, X., TL, L., MA, E., CH, M., PC, W., WB, I., & J., L. (2026). Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation.. Prostate. https://doi.org/10.1002/pros.70133

Source records

europe-pmc · retrieved 2026-09-27T07:22:42.000Z